Adipose Tissue-Derived Stem Cells from Type 2 Diabetics Reveal Conservative Alterations in Multidimensional

Le Wang1,2,3, Leisheng Zhang4, Xue Liang2

  • 1Organ Transplant Center, Tianjin First Central Hospital, Nankai University, Tianjin, China.

Abstract

Insights

Mesenchymal stem cells from type 2 diabetes patients (T2DM-ASCs) show altered differentiation and cell cycle but retain stemness. These findings suggest potential for autologous cell-based therapies for type 2 diabetes mellitus (T2DM).

Area of Science:

  • Stem cell biology
  • Metabolic disease research
  • Regenerative medicine

Background:

  • Adipose tissue-derived mesenchymal stem cells (ASCs) are promising for treating type 2 diabetes mellitus (T2DM).
  • Understanding T2DM-ASC characteristics is crucial for effective therapeutic development.
  • Patient-specific ASC alterations remain largely unclear, hindering pathogenesis insights.

Purpose of the Study:

  • To investigate the distinct characteristics of ASCs derived from type 2 diabetic patients (T2DM-ASCs) compared to non-diabetic donors (ND-ASCs).
  • To evaluate potential alterations in immunophenotype, differentiation capacity, cell cycle, and cytokine profiles.

Main Methods:

  • Isolation of peripancreatic ASCs from human T2DM and non-diabetic donors.
  • Comparative analysis of immunophenotype, cell vitality, differentiation potential (chondrogenic, adipogenic, osteogenic), stemness, migration, immunomodulatory capacity, cell cycle, and cytokine expression.

Main Results:

  • T2DM-ASCs and ND-ASCs showed similar immunophenotype, vitality, chondrogenic differentiation, and stemness.
  • T2DM-ASCs exhibited altered migration and immunoregulatory functions.
  • Deficiencies in adipogenic and osteogenic differentiation were observed in T2DM-ASCs.
  • Delayed cell cycle progression and a distinct cytokine expression spectrum were noted in T2DM-ASCs.

Conclusions:

  • T2DM-ASCs possess conserved stemness but exhibit specific functional and differentiation alterations.
  • These findings support the potential for autologous ASC application in future cell-based T2DM therapies.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.0K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.5K